Search Results - "Laurent Cals"

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study by Raoul, Jean-Luc, Van Laethem, Jean-Luc, Peeters, Marc, Brezault, Catherine, Husseini, Fares, Cals, Laurent, Nippgen, Johannes, Loos, Anja-Helena, Rougier, Philippe

“…This study was designed to investigate the efficacy and safety of the epidermal growth factor receptor (EGFR) inhibitor cetuximab combined with irinotecan,…”
Get full text

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy by Verlut, Clotilde, Mouillet, Guillaume, Magnin, Eloi, Buffet-Miny, Joëlle, Viennet, Gabriel, Cattin, Françoise, Billon-Grand, Nora Clelia, Bonnet, Emilie, Servagi-Vernat, Stéphanie, Godard, Joël, Billon-Grand, Romain, Petit, Antoine, Moulin, Thierry, Cals, Laurent, Pivot, Xavier, Curtit, Elsa

“…Introduction: Temozolomide and concomitant radiotherapy followed by temozolomide has been used as a standard therapy for the treatment of newly diagnosed…”
Get full text

Is extracapsular tumour spread a prognostic factor in patients with early breast cancer? by Dobi, Erion, Bazan, Fernando, Dufresne, Armelle, Demarchi, Martin, Villanueva, Cristian, Chaigneau, Loic, Montcuquet, Philipe, Ivanaj, Arben, Sautière, Jean Loup, Maisonnette-Escot, Yolande, Cals, Laurent, Algros, Marie Paule, Woronoff, Anne-Sophie, Pivot, Xavier

“…Background This study searched for extra capsular tumour spread (ECS) as a prognostic factor for recurrence in terms of Disease Free Survival (DFS) and Overall…”
Get full text

Impact of organised programs on colorectal cancer screening by EISINGER, F, CALS, L, CALAZEL-BENQUE, A, BLAY, J.Y, COSCAS, Y, DOLBEAULT, S

“…Colorectal cancer (CRC) screening has been shown to decrease CRC mortality. Organised mass screening programs are being implemented in France. Its perception…”
Get full text

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis by Curtit, Elsa, Nerich, Virginie, Mansi, Laura, Chaigneau, Loic, Cals, Laurent, Villanueva, Cristian, Bazan, Fernando, Montcuquet, Philippe, Meneveau, Nathalie, Perrin, Sophie, Algros, Marie‐Paule, Pivot, Xavier

“…Background. The primary aim of this retrospective study was to investigate intraindividual correlation of estrogen receptor (ER) status, progesterone receptor…”
Get full text

Cabazitaxel: A Novel Microtubule Inhibitor by Villanueva, Cristian, Bazan, Fernando, Kim, Stefano, Demarchi, Martin, Chaigneau, Loïc, Thiery-Vuillemin, Antoine, Nguyen, Thierry, Cals, Laurent, Dobi, Erion, Pivot, Xavier

“…The development of drug resistance is a major obstacle to effective cancer therapy. Several agents are in clinical development with the goal of overcoming…”
Get full text

Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia by Kamioner, Didier, Fruehauf, Stefan, Maloisel, Fréderic, Cals, Laurent, Lepretre, Stéphane, Berthou, Christian

“…Nivestim™ (filgrastim) is a follow-on biologic agent licensed in the EU for the treatment of neutropenia and febrile neutropenia induced by myelosuppressive…”
Get full text

Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions by Fiteni, Frederic, Villanueva, Cristian, Bazan, Fernando, Perrin, Sophie, Chaigneau, Loic, Dobi, Erion, Montcuquet, Philippe, Cals, Laurent, Meneveau, Nathalie, Nerich, Virginie, Limat, Samuel, Pivot, Xavier

“…Abstract Purpose Trastuzumab in Human Epidermal growth Receptor 2-positive (HER2+) metastatic breast cancer (MBC) was established as standard therapy since…”
Get full text

Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study by Voidey, Aline, Pivot, Xavier, Woronoff, Anne-Sophie, Nallet, Gilles, Cals, Laurent, Schwetterle, Francis, Limat, Samuel

“…One of the main measures of the French national cancer plan is to encourage physicians to work collectively, and to minimize territorial inequities in access…”
Get full text

Overall survival according to tumoral clusterin expression in breast cancer by Mouillet, Guillaume, Chaigneau, Loic, Michy, Thierry, Villanueva, Cristian, Bazan, Fernando, Almotlak, Hamadi, Curtit, Elsa, Cals, Laurent, Montcuquet, Philippe, Meneveau, Nathalie, Algros, Marie-Paule, Pivot, Xavier B.

“…Abstract only e11579 Background: Clusterin (CLU) is a glycoprotein expressed constitutively in many tissues and involved in various physiopathological…”
Get full text

Cost-effectiveness analysis of routine use of eribulin in patients with metastatic breast cancer in France: A retrospective analysis by Paillard, Marie-Justine, Curtit, Elsa, Nerich, Virginie, Cals, Laurent, Bazan, Fernando, Mansi, Laura, Meneveau, Nathalie, Montcuquet, Philippe, Dobi, Erion, Chaigneau, Loic, Almotlak, Hamadi, Thiery-Vuillemin, Antoine, Villanueva, Cristian, Pivot, Xavier B.

“…Abstract only…”
Get full text

Sentinel lymph nodes before chemotherapy: The Besançon experience by Chaigneau, Loic, gannard Pechin, Elsa, Almotlac, Hamidi, Mouillet, Guillaume, Bazan, Fernando, Villanueva, Cristian, Cals, Laurent, Montcuquet, Philippe, Meneveau, Nathalie, Nguyen, Thierry, Curtit, Elsa, Sautiere, Jean-Loup, Maisonnette, Yolande, Algros, Marie-Paule, Pivot, Xavier B.

“…Abstract only 1122 Background: It is debatable whether sentinal lymph node (SLN), before chemotherapy in locally breast cancer (LBC) is feasible. Impact on…”
Get full text

Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU‐related toxicity by Magné, Nicolas, Etienne‐Grimaldi, Marie‐Christine, Cals, Laurent, Renée, Nicole, Formento, Jean‐Louis, Francoual, Mireille, Milano, Gérard

“…What is already known about this subject • Dihydropyrimidine dehydrogenase (DPD) deficiency is known to be a major cause of severe 5FU‐related toxicity. • A…”
Get full text

Management of Anemia in Advanced Breast and Lung Cancer Patients in Daily Practice: Results of a French Survey by Ray-Coquard, Isabelle, Morère, Jean-François, Scotté, Florian, Cals, Laurent, Antoine, Eric-Charles

“…Introduction The purpose of this French survey was to evaluate the adherence to the guidelines (European Organisation for Research and Treatment of Cancer…”
Get full text

Cabazitaxel by Villanueva, Cristian, Bazan, Fernando, Kim, Stefano, Demarchi, Martin, Chaigneau, Loïc, Thiery-Vuillemin, Antoine, Nguyen, Thierry, Cals, Laurent, Dobi, Erion, Pivot, Xavier

“…The development of drug resistance is a major obstacle to effective cancer therapy. Several agents are in clinical development with the goal of overcoming…”
Get full text

Prevalence and management of pain in patients with metastatic cancer in Franche-Comté by Dénommé, Fanny, Kroemer, Marie, Montcuquet, Philippe, Nallet, Gilles, Thiery-Vuillemin, Antoine, Bazan, Fernando, Mouillet, Guillaume, Villanueva, Cristian, Demarchi, Martin, Stein, Ulrich, Almotlak, Hamadi, Chaigneau, Loïc, Curtit, Elsa, Meneveau, Nathalie, Maurina, Tristan, Dobi, Erion, Hon, Thierry Nguyen Tan, Cals, Laurent, Mansi, Laura, Verlut, Clotilde, Pana-Katatali, Héloïse, Caubet, Mathieu, Paillard, Marie-Justine, Limat, Samuel, Pivot, Xavier, Nerich, Virginie

“…Pain management is a major public health problem, especially in oncology. In order to assess professional practice, the IRFC-FC conducted a survey amongst…”
Get more information

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy by Clotilde Verlut, Guillaume Mouillet, Eloi Magnin, Joëlle Buffet-Miny, Gabriel Viennet, Françoise Cattin, Nora Clelia Billon-Grand, Emilie Bonnet, Stéphanie Servagi-Vernat, Joël Godard, Romain Billon-Grand, Antoine Petit, Thierry Moulin, Laurent Cals, Xavier Pivot, Elsa Curtit

“…Introduction Temozolomide and concomitant radiotherapy followed by temozolomide has been used as a standard therapy for the treatment of newly diagnosed…”
Get full text

Cancer screening in France: subjects' and physicians' attitudes by Eisinger, François, Blay, Jean-Yves, Morère, Jean-François, Rixe, Olivier, Calazel-Benque, Anne, Cals, Laurent, Coscas, Yvan, Dolbeault, Sylvie, Namer, Moïse, Serin, Daniel, Roussel, Claire, Pivot, Xavier

“…Objective Since screening for cancer has been advocated, funded, and promoted in France, it is important to evaluate the attitudes of subjects in the general…”
Get full text

Follow-up in patients with early breast cancer by Maurina, Tristan, Chaigneau, Loïc, Bazan, Fernando, Villanueva, Christian, Thiery-Vuillemin, Antoine, Kalbacher, Elsa, Curtit, Elsa, Cals, Laurent, N'guyen, Thierry, Pivot, Xavier

“…Breast cancer incidence remains the highest among gynaecologic neoplasms. Once they have achieved their treatments, patients should undergo careful follow-up…”
Get more information

Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients by Cals, L., Rixe, O., François, E., Favre, R., Merad, L., Deplanque, G., Laadem, A., Juin, P., Bereder, J. M., Bernardini, D., Herait, P.

“…Purpose: To determine maximum tolerated dose, safety and efficacy of weekly 24 h infusional 5-fluorouracil (5-FU) combined alternately with oxaliplatin and…”
Get full text